HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hemodynamic effect of methylepoxyproscillaridin (P35) in patients with congestive myocardiopathy.

Abstract
The hemodynamic effect of methylepoxyproscillaridin (3'-methyl-4'-5'-epoxy-proscillaridin) (P35) was studied according to the Swan Ganz thermodilution method in 6 patients with latent cardiac insufficiency. Both at rest and under ergometer exercise, the stroke volume and the systolic blood pressures increased under P35. Moreover, under physical exercise the heart rate decreased significantly, while cardiac output increased. The hemodynamic effect of P35 can therefore be regarded as typical of cardiac glycosides.
AuthorsJ Bonelli, D Magometschnig, F Gazo
JournalInternational journal of clinical pharmacology, therapy, and toxicology (Int J Clin Pharmacol Ther Toxicol) Vol. 26 Issue 5 Pg. 243-5 (May 1988) ISSN: 0174-4879 [Print] Germany
PMID3410600 (Publication Type: Journal Article)
Chemical References
  • Bufanolides
  • Cardiac Glycosides
  • methylepoxyproscillaridin
  • Proscillaridin
Topics
  • Aged
  • Blood Pressure (drug effects)
  • Bufanolides (pharmacology)
  • Cardiac Glycosides (pharmacology)
  • Heart Failure (physiopathology)
  • Hemodynamics (drug effects)
  • Humans
  • Middle Aged
  • Proscillaridin (analogs & derivatives, pharmacology)
  • Stroke Volume (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: